Non-surgical Jowl and Jawline Rejuvenation with Resorbable Suspension Threads and Superficial Enhanced Fluid Fat Injection (SEFFI)
Journal Title: Journal of Regenerative Medicine & Biology Research - Year 2022, Vol 3, Issue 1
Abstract
Background: Collagen and elastin play a crucial role in skin traction; their deterioration contributes to causing skin sagging and laxity with time. Soft tissue ptosis modifies the mandibular profile in addition to enhancing the nasolabial folds, lines of puppets and lateral eyebrow area; moreover, skin atrophy and volume loss are major factors involved in facial aging, contributing to the formation of facial rhytids, skeletonization, and pseudo-descent of the midface. Non-surgical face and neck rejuvenation lift with resorbable suspension threads and Superficial Enhanced Fluid Fat Injection (SEFFI) can be used as a temporary procedure until the aging appearance requires a more radical approach. Methods: Retrospective analysis from January 2019 to February 2022 of a 232 cases series of patients seeking a rejuvenation of the lower frame of the face (jowls and jawline) included in the study. The cases were performed in the base-office medical suites of some of the Authors. All of them were treated with resorbable threads in the face subcutis without modifying the superficial musculoaponeurotic system and platysma. Result: Data collection on base-office medical suites treatment time, size and length selection, and post- treatment complications were included. The most frequent complication was bruise in the harvesting area (healed within 3-7 days) and in the jowl and jawline; cases of skin irregularities in threads (all cases solved 7-10 days); no skin irregularities or lumpiness in tissue graft. Conclusion: Non-surgical face and neck treatment with resorbable suspension threads and Superficial Enhanced Fluid Fat Injection (SEFFI) getting a valid method as a temporary procedure until the aging appearance requires a more radical approach.
Authors and Affiliations
Mattia Colli1*, Alessandro Gennai2, Rosalba Russo3, Andrea Tomeo4, Bruno Bovani5, Domenico Piccolo6, Fabrizio Melfa7, Piero Tesauro8, Alberto Diaspro9
Keywords
Related Articles
- EP ID EP702455
- DOI https://doi.org/10.46889/JRMBR.2022.3102
- Views 61
- Downloads 0
Subcutaneous and Intravenous Administration of Human Umbilical Cord Mesenchymal Stem Cells in Patient With Multiple Foot Ulcers Complicated by Scleroderma- A Case Report with One Year Follow Up
We treated a patient with progressive, refractory scleroderma with multiple ulcers on her feet with a combination of intravenous and a subcutaneous injection at the periphery of the ulcers using Umbilical Cord-Derived Me...
Expression of Neuron Specific Neuronal Nuclei Protein (NeuNNP) by AAV2 Shows Diagnosis Ability in Spinal Cord Injury Using Neural Stem Cells
Fibroblast Growth Factor (FGF) shows promising therapy for Spinal Cord Injury (SCI). Neural stem transplantation has been on the role implementing tactics to repair SCI. Considering the hostile hypoxia condition in SCI...
The Use of Stem Cell Therapy in the Treatment of Autism Spectrum Disorder
Research on the use of stem cell therapy in regenerative medicine has shown great potential in the treatment of neurological disorders. Specifically, mesenchymal stem cells, adult stem cells from the umbilical cord and e...
A Gout Flare Caused by the Administration of Platelet Rich Plasma: A Clinical Case
The therapy with Platelet Rich Plasma (PRP) administered in degenerated or injured musculoskeletal tissues is a new and promising regenerative treatment option. Traditionally, it is considered that as PRP represents an a...
Bioregenerative Applications of the Human Mesenchymal Stem Cell- Derived Secretome: Part-I
Mesenchymal stem cells hold many therapeutic benefits in treating diverse disease states, but autologous requirements, high costs, lack of standardization and other factors limit their widespread application. Additionall...